Pharmacokinetic drug interactions of vinca alkaloids: Summary of case reports

Pharmacotherapy

Volumn 18, Issue 6 I, 1998, Pages 1304-1307

  Chan, Jeannie D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; AZITHROMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOCHROME P450; DAUNORUBICIN; ERYTHROMYCIN; ISONIAZID; ITRACONAZOLE; METHOTREXATE; NIFEDIPINE; PREDNISONE; VERAPAMIL; VINCA ALKALOID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG METABOLISM; HUMAN; MULTIPLE MYELOMA; NEUROTOXICITY; PLASMA HALF LIFE; REVIEW;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; VINCA ALKALOIDS; VINCRISTINE;

EID: 0031755809     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-gylcoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129-34.
2. Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 1995;40:523-30.
3. Rahmani R, Zhou XJ. Pharmacokinetics and metabolism of vinca alkaloids. Cancer Surv 1993;17:269-81.
4. Zhou-Pan XR, Seree E, Zhou XJ, et al. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions. Cancer Res 1993;53:5121-6.
5. Crom WR, de Graaf SS, Synold T, et al. Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia. J Pediatr 1994;125(4):642-9.
6. Zhou XJ, Zhou-Pan XR, Gauthier T, et al. Human liver microsomal cytochrome P450 3A isoenzymes mediated vindesine biotransformation. Biochem Pharmacol 1993;45: 853-61.
7. Bohme A, Ganser A, Hoelzer D. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Ann Hematol 1995;71:311-12.
8. Murphy JA, Ross LM, Gibson BE. Vincristine toxicity in five children with acute lymphoblastic leukaemia. Lancet 1995;346:443.
9. Carrion C, Espinosa E, Herrero A, et al. Possible vincristine-isoniazid interaction. Ann Pharmacol 1995;29:201.
10. Fedeli L, Colozza M, Boschetti E, et al. Pharmacokinetics of vincristine in cancer patients treated with nifedipine. Cancer 1989;64:1805-11.
11. Abdel-Rahman M, Wosch F, Harder S, et al. Interaction between verapamil and vincristine binding to plasma proteins. Int J Clin Pharmacol Ther Toxicol 1992;30(11):536-7.
12. Bertrand Y, Capdevile R, Balduck N, et al. Cyclosporin A used to reverse drug resistance increases vincristine neurotoxicity. Am J Hematol 1992;40:158-9.
13. Weber DM, Dimopoulos MA, Alexanian R. Increased neurotoxicity with VAD-cyclosporin in multiple myeloma. Lancet 1993;341:558-9.